H-E-B — Class II drug recall D-0152-2021
Terminated recall by Taro Pharmaceuticals U.S.A., Inc., reported 2020-12-23, distributed nationwide. Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the
| Recall number | D-0152-2021 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY, United States |
| Recall initiated | 2020-11-17 |
| Classified | 2020-12-16 |
| Reported by FDA | 2020-12-23 |
| Terminated | 2024-02-21 |
| Distributed | Nationwide (US) |
| Countries outside the US | CA |
| Reason classes | specification failure |
| NDC | 37808-0305, 37808-0305-01 |
| Lot numbers | A873630558, D867331276, DEC-2020, MAR-2021 |
Product
H-E-B - Athlete's Foot Cream Clotrimazole Cream USP, 1% Anitfungal NET WT. 0.5 oz. (14.2 g), Made with Pride & Care for H-E-B San Antonio, TX 78204 Made in Canada NDC 37808-305-01
Reason for recall
Failed Impurities/Degradation Specifications: An unknown degradation impurity was detected slightly above the specification limit in Clotrimazole Cream USP 1%.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0152-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.